Treatment for rheumatoid arthritis

Details Treatment for rheumatoid arthritis Treatment for rheumatoid arthritis

A - Human Necessities

61

K

A61K 38/22 (2006.01)

Patent

CA 2175457

Administration of corticotropin-releasing factor to patients suffering from one of the chronic inflammatory athritides, such as rheumatoid arthritis, reduces episodic acute inflammatory responses to the chronic disease. Doses of administered CRF in accordance with the invention give anti-inflammatory results in a dose responsive manner even in well-established disease.

L'administration du facteur de libération de la corticotropine (FLC) à des patients souffrant d'une arthrite inflammatoire telle que l'arthrite rhumatoïde a pour effet de réduire les réponses inflammatoires aiguës épisodiques symptomatiques de la chronicité de la maladie. Les doses de FLC prévues par l'invention ont des effets anti-inflammatoires, même dans les cas d'affections bien installées.

Affiliated with

Also associated with

Rating

Treatment for rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for rheumatoid arthritis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1450238